[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "2019-002491-14"
            }
        ],
        "amendment_date": null,
        "keywords": null,
        "dcp_id": null,
        "interventional_model": "Parallel",
        "lead_org": "Hoffmann-La Roche",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Participants with a first diagnosis of HCC who have undergone either a curative resection or ablation (radiofrequency ablation [RFA] or microwave ablation [MVA] only) within 4-12 weeks prior to randomization"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Documented diagnosis of HCC that has been completely resected or ablated (RFA or MVA only)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Absence of major macrovascular invasion (except Vp1/Vp2) and extrahepatic spread"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Absence of extrahepatic spread as confirmed by CT or MRI scan of the chest, abdomen, pelvis, and head prior to and following curative procedure"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Full recovery from surgical resection or ablation within 4 weeks prior to randomization"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "High risk for HCC recurrence after resection or ablation"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "For patients who received post-operative transarterial chemoembolization: full recovery from the procedure within 4 weeks prior to randomization"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "For patients with resected HCC, availability of a representative baseline tumor tissue sample"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "ECOG Performance Status of 0 or 1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Child-Pugh Class A status"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "Adequate hematologic and end-organ function"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "For women of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive methods"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "For men: agreement to remain abstinent (refrain from heterosexual intercourse) or use a condom, and agreement to refrain from donating sperm"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 13,
                    "description": "Known fibrolamellar HCC, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 14,
                    "description": "Evidence of residual, recurrent, or metastatic disease at randomization"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 15,
                    "description": "Clinically significant ascites"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 16,
                    "description": "History of hepatic encephalopathy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 17,
                    "description": "Prior bleeding event due to untreated or incompletely treated esophageal and/or gastric varices within 6 months prior to randomization"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "Have received more than 1 cycle of adjuvant TACE following surgical resection"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "Active or history of autoimmune disease or immune deficiency"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "History of idiopathic pulmonary fibrosis, organizing pneumonia, drug-induced pneumonitis, or idiopathic pneumonitis, or evidence of active pneumonitis on screening chest CT scan"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Significant cardiovascular disease within 3 months prior to Day 1 of Cycle 1, unstable arrhythmia, or unstable angina"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "History of malignancy other than HCC within 5 years prior to screening, with the exception of malignancies with a negligible risk of metastasis or death"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "Active tuberculosis"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "Any other disease, metabolic dysfunction, physical examination finding, or clinical laboratory finding that contraindicates the use of an investigational drug, may affect the interpretation of the results, or may render the patient at high risk from treatment complications"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 25,
                    "description": "Pregnant or breastfeeding, or intending to become pregnant during the study or within 5 months after the final dose of atezolizumab or within 6 months after the final dose of bevacizumab. Women of childbearing potential must have a negative serum pregnancy test result within 14 days prior to Day 1 of Cycle 1."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 26,
                    "description": "Co-infection with HBV and HCV"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 27,
                    "description": "Co-infection with HBV and hepatitis D viral infection"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 28,
                    "description": "Clinical significant uncontrolled or symptomatic hypercalcemia"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 29,
                    "description": "Any treatment for HCC prior to resection or ablation, including systemic therapy and locoregional therapy such as TACE"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 30,
                    "description": "Treatment with systemic immunostimulatory or immunosuppressive agents"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 31,
                    "description": "Inadequately controlled arterial hypertension"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 32,
                    "description": "History of hypertensive crisis or hypertensive encephalopathy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 33,
                    "description": "Significant vascular disease"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 34,
                    "description": "Evidence of bleeding diathesis or significant coagulopathy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 35,
                    "description": "Current or recent use of aspirin or full-dose oral or parenteral anticoagulants"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 36,
                    "description": "Core biopsy within 3 days of Day 1 of Cycle 1"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 37,
                    "description": "History of GI fistula, GI perforation, or intra-abdominal abscess"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 38,
                    "description": "Serious non-healing or dehiscing wound"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 39,
                    "description": "Major surgical procedure within four weeks"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 40,
                    "description": "Chronic daily treatment with a non-steroidal anti-inflammatory drug"
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": null,
        "official_title": "A Phase III, Multicenter, Randomized, Open-Label Study of Atezolizumab (Anti-PD-L1 Antibody) Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation",
        "_phase_sort_order": 0,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Prior to any drug administration on Day 1 of Cycles 1, 2, 3, 4, 8, 12, and 16 (each cycle is 21 days)",
                "name": "Number of Participants with Anti-Drug Antibodies (ADAs) to Atezolizumab",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline to 24 and 36 months",
                "name": "OS Rate at 24 and 36 Months",
                "description": "OS rate defined as the proportion of patients who have not experienced death from any cause at 24 and 36 months after randomization.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to approximately 91 months",
                "name": "Overall Survival (OS)",
                "description": "OS is defined as the time from randomization to death from any cause.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to approximately 91 months",
                "name": "Percentage of Participants With Adverse Events",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to approximately 39 months",
                "name": "Recurrence-Free Survival (RFS), as Determined by IRF",
                "description": "RFS is defined as the time from randomization to the first documented occurrence of intrahepatic or extrahepatic HCC as determined by an IRF, or death from any cause (whichever occurs first).",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Baseline up to approximately 91 months",
                "name": "RFS as Determined by the Investigator",
                "description": "RFS is defined as the time from randomization to the first documented occurrence of intrahepatic or extrahepatic HCC as determined by an investigator, or death from any cause (whichever occurs first).",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to approximately 91 months",
                "name": "RFS in Pd-L1-High Subgroup",
                "description": "RFS after randomization as determined by the investigator and by an IRF, among patients in the PD-L1-high subgroup.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Randomization up to 24 months and up to 36 months",
                "name": "RFS Rate at 24 and 36 Months, as Assessed by the Investigator",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Randomization up to 24 months and up to 36 months",
                "name": "RFS Rate at 24 and 36 Months, as Assessed by the IRF",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Prior to any drug administration on Day 1 of Cycles 1, 2, 3, 4, 8, 12, and 16 (each cycle is 21 days)",
                "name": "Serum Concentration of Atezolizumab",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to approximately 91 months",
                "name": "Time to Extrahepatic Spread (EHS) or Macrovascular Invasion",
                "description": "Time to EHS or macrovascular invasion after randomization, defined as the time from randomization to the first appearance of EHS or macrovascular invasion, as determined by the investigator.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to approximately 91 months",
                "name": "Time to Recurrence (TTR)",
                "description": "TTR defined as the time from randomization to first documented occurrence of intrahepatic or extrahepatic HCC, as determined by the investigator and by an IRF.",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "III",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 2,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04102098",
        "biomarkers": [],
        "classification_code": null,
        "current_trial_status_date": "2022-01-05",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "LIHC",
                    "CARCINOMA, HEPATOCELLULAR, MALIGNANT",
                    "Liver Cell Carcinoma",
                    "Primary Carcinoma of the Liver Cells",
                    "Hepatoma",
                    "Carcinoma of Liver Cells",
                    "Carcinoma of the Liver Cells",
                    "Liver Cell Cancer (Hepatocellular Carcinoma)",
                    "Hepatocellular Cancer",
                    "Primary Carcinoma of Liver Cells",
                    "HCC"
                ],
                "nci_thesaurus_concept_id": "C3099",
                "name": "Hepatocellular Carcinoma",
                "type": [
                    "maintype",
                    "subtype"
                ],
                "parents": [
                    "C7927",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Hepatocellular Carcinoma",
                    "Relapsed Hepatocellular Carcinoma",
                    "Recurrent Carcinoma of Liver Cell",
                    "Recurrent Liver Cell Carcinoma",
                    "Relapsed Carcinoma of the Liver Cell",
                    "Hepatocellular Carcinoma, Recurrent",
                    "Relapsed Hepatoma",
                    "Recurrent Hepatoma",
                    "Relapsed Carcinoma of Liver Cell",
                    "Relapsed Liver Cell Carcinoma",
                    "Recurrent Carcinoma of the Liver Cell"
                ],
                "nci_thesaurus_concept_id": "C9264",
                "name": "Recurrent Hepatocellular Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C3099",
                    "C131500",
                    "C159565",
                    "C7110"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disorder of Digestive System",
                    "Gastrointestinal System Disease",
                    "Digestive Disease",
                    "GI Disorder",
                    "Gastrointestinal Disorder",
                    "Digestive System Disease",
                    "Gastrointestinal System Disorder",
                    "Unspecified Gastrointestinal Problem",
                    "stomach or intestinal disorder"
                ],
                "nci_thesaurus_concept_id": "C2990",
                "name": "Digestive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Cancer of Liver",
                    "Liver and Intrahepatic Biliary Tract Carcinoma",
                    "Liver and hepatobiliary cancer, NOS",
                    "Primary Liver Carcinoma",
                    "Cancer of the Liver",
                    "Liver Carcinoma",
                    "Biliary Tract Cancer",
                    "Cancer of the Liver and Intrahepatic Biliary Tract",
                    "Liver and Intrahepatic Bile Duct Carcinoma",
                    "Cancer of Liver and Intrahepatic Biliary Tract",
                    "Liver and Intrahepatic Bile Duct Cancer",
                    "Liver/hepatobiliary cancer",
                    "Liver and Intrahepatic Biliary Tract Cancer"
                ],
                "nci_thesaurus_concept_id": "C7927",
                "name": "Liver Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C34803",
                    "C96963",
                    "C7106"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Liver and Biliary Neoplasm",
                    "Malignant Liver and Biliary System Neoplasm",
                    "Malignant Hepato-Biliary Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8609",
                "name": "Malignant Hepatobiliary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8614",
                    "C4890"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor of the Digestive System",
                    "Digestive System Tumor",
                    "Digestive Neoplasm",
                    "Gastrointestinal Neoplasm",
                    "Gastrointestinal Tumor",
                    "Neoplasm of the GI System",
                    "Neoplasm of the Gastrointestinal System",
                    "Tumor of GI System",
                    "GI Neoplasm",
                    "Neoplasm of the Digestive System",
                    "Tumor of the GI System",
                    "Neoplasm of GI System",
                    "GI System Tumor",
                    "Neoplasm of Gastrointestinal System",
                    "Tumor of Gastrointestinal System",
                    "GI System Neoplasm",
                    "Neoplasm of Digestive System",
                    "Tumor of Digestive System",
                    "Tumor of the Gastrointestinal System",
                    "Digestive Tumor",
                    "GI Tumor",
                    "Gastrointestinal System Neoplasm",
                    "Gastrointestinal System Tumor"
                ],
                "nci_thesaurus_concept_id": "C3052",
                "name": "Digestive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2990",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Hepato-Biliary Tumor",
                    "Hepatic and Biliary Neoplasms",
                    "Hepatobiliary Tumors",
                    "Liver and Biliary System Neoplasm",
                    "Hepatic, Biliary, and Gallbladder Neoplasms",
                    "Hepatobiliary Tumor",
                    "Hepatic and Biliary Tumors",
                    "Liver and Biliary Neoplasm",
                    "Hepato-Biliary Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8614",
                "name": "Hepatobiliary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3959",
                    "C3052"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Hepatic and Intrahepatic Bile Duct Neoplasm",
                    "Liver Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7103",
                "name": "Liver and Intrahepatic Bile Duct Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8614",
                    "C3196"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C190593",
                "name": "Malignant Liver Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7103",
                    "C8609"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Gastrointestinal System Neoplasm",
                    "Malignant Digestive System Neoplasm",
                    "Gastrointestinal System Cancer",
                    "Gastrointestinal cancer, NOS"
                ],
                "nci_thesaurus_concept_id": "C4890",
                "name": "Malignant Gastrointestinal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C3052"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Liver and Intrahepatic Bile Duct Epithelial Neoplasm",
                    "Epithelial Hepatic and Intrahepatic Bile Duct Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7106",
                "name": "Liver Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7103"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Liver Disease",
                    "Hepatic Disorder",
                    "Liver Disorder"
                ],
                "nci_thesaurus_concept_id": "C3196",
                "name": "Liver and Intrahepatic Bile Duct Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3959"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Primary Malignant Neoplasm of Liver"
                ],
                "nci_thesaurus_concept_id": "C34803",
                "name": "Primary Malignant Liver Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C190593"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor_Morphology",
                    "Tumor Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Epithelial Neoplasm",
                    "Epithelial tumor, malignant",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Malignant Epithelioma",
                    "Epithelioma Malignant",
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Epithelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9305",
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Liver Disease",
                    "Liver and Biliary Disease",
                    "Liver and Biliary Disorder",
                    "Liver and Biliary System Disorder"
                ],
                "nci_thesaurus_concept_id": "C3959",
                "name": "Hepatobiliary Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2990"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Gastrointestinal System Carcinoma",
                    "Carcinoma of the Gastrointestinal System"
                ],
                "nci_thesaurus_concept_id": "C96963",
                "name": "Digestive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4890"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Primary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C131500",
                "name": "Recurrent Primary Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C159565",
                "name": "Recurrent Adenocarcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C2852",
                    "C7619"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Cancer of Liver",
                    "Relapsed Cancer of the Liver",
                    "Recurrent Cancer of the Liver",
                    "Recurrent Liver Carcinoma",
                    "Relapsed Liver Cancer",
                    "Relapsed Cancer of Liver"
                ],
                "nci_thesaurus_concept_id": "C7110",
                "name": "Recurrent Liver Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7927",
                    "C7622"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Gastrointestinal System Cancer",
                    "Recurrent Gastrointestinal System Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C7622",
                "name": "Recurrent Digestive System Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C96963",
                    "C7619"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm Recurrence",
                    "Recurrence",
                    "Recurrent Tumor",
                    "Recurrent"
                ],
                "nci_thesaurus_concept_id": "C4798",
                "name": "Recurrent Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Relapsed Cancer",
                    "Relapsed Carcinoma",
                    "Recurrent Cancer"
                ],
                "nci_thesaurus_concept_id": "C7619",
                "name": "Recurrent Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent Cancer",
                    "Recurrent Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C4813",
                "name": "Recurrent Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4798",
                    "C9305"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "WO41535",
        "active_sites_count": 3,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [],
                "name": "Arm A (atezolizumab plus bevacizumab)",
                "description": "Participants will receive Atezolizumab + Bevacizumab until disease recurrence or unacceptable toxicity.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Arm B (active surveillance)",
                "description": "Active surveillance of participants.",
                "type": "NO_INTERVENTION"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biologicals",
                            "Biological Products",
                            "Biologics",
                            "Immunologic, Immunochemical",
                            "Biopharmaceuticals",
                            "Immunologics"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C128057",
                        "name": "Anti-PD-L1 Monoclonal Antibody",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C191689",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiangiogenesis Agents",
                            "Anti-Angiogenic Agents",
                            "Antiangiogenic Agent",
                            "Angiogenesis Blockers",
                            "Angiogenesis Antagonists"
                        ],
                        "nci_thesaurus_concept_id": "C1742",
                        "name": "Angiogenesis Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Anti-Tumor Drugs",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Antiproliferative Agents",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs",
                            "Cancer Drug",
                            "Antineoplastics"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-PD-L1 Agent",
                            "PD-L1-targeting Agent",
                            "Anti-CD274 Agent",
                            "CD274-targeting Agent"
                        ],
                        "nci_thesaurus_concept_id": "C191689",
                        "name": "PD-L1 Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C156893"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biological Response Modifier",
                            "Immunotherapy Agent",
                            "Immunomodulators",
                            "Immunotherapeutic Agent",
                            "Immunopotentiators",
                            "Immune Modulators",
                            "Immune Mediators",
                            "Immune Regulators",
                            "Biomodulators",
                            "Immunomodulating Agent",
                            "Immunomodulatory Agent",
                            "BRM"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibodies",
                            "Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Antineoplastic Ab",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody Anti-VEGF"
                        ],
                        "nci_thesaurus_concept_id": "C2496",
                        "name": "Anti-VEGF Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1742",
                            "C163758",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biologicals",
                            "Biological Products",
                            "Biologics",
                            "Immunologic, Immunochemical",
                            "Biopharmaceuticals",
                            "Immunologics"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Pharmacologic Agent",
                            "Drug",
                            "Agent",
                            "Pharmacological Substance",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibodies",
                            "Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Anti-Tumor Drugs",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Antiproliferative Agents",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs",
                            "Cancer Drug",
                            "Antineoplastics"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Pharmacologic Agent",
                            "Drug",
                            "Agent",
                            "Pharmacological Substance",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Biological Agent",
                            "Anticancer Biological",
                            "Antineoplastic Biotherapeutic",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biological Response Modifier",
                            "Immunotherapy Agent",
                            "Immunomodulators",
                            "Immunotherapeutic Agent",
                            "Immunopotentiators",
                            "Immune Modulators",
                            "Immune Mediators",
                            "Immune Regulators",
                            "Biomodulators",
                            "Immunomodulating Agent",
                            "Immunomodulatory Agent",
                            "BRM"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Tecentriq"
                        ],
                        "nci_thesaurus_concept_id": "C106250",
                        "name": "Atezolizumab",
                        "description": "A human, Fc optimized, monoclonal antibody directed against the protein ligand PD-L1 (programmed cell death-1 ligand 1) with potential immunomodulating and antineoplastic activities. Anti-PD-L1 monoclonal antibody MPDL3280A binds to PD-L1, blocking its binding to and activation of its receptor, PD-1 (programmed death 1), which may enhance the T-cell-mediated immune response to neoplasms and reverse T-cell inactivation. In addition, by binding to PD-L1, MPDL3280A also prevents binding of this ligand to B7.1. PD-L1 is overexpressed on many human cancer cell types. PD-L1 binding to PD-1 on T-cells suppresses the immune system and results in increased immune evasion. PD-1, a transmembrane protein expressed on activated T-cells, is a negative regulator of the immune system that limits the expansion and survival of CD8+ T cells. The Fc region of MPDL3280A is modified in such a way that it does not induce either antibody-dependent cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC)",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C128057"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Zirabev",
                            "Mvasi",
                            "Avastin"
                        ],
                        "nci_thesaurus_concept_id": "C2039",
                        "name": "Bevacizumab",
                        "description": "A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine.  Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C2496"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PD-1 Ligand-targeting Agent",
                            "PD-1 Ligands Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C156893",
                        "name": "PD-1 Ligand Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C143250",
                            "C163758"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2019-07238",
        "why_study_stopped": null,
        "brief_summary": "This study will evaluate the efficacy and safety of adjuvant therapy with atezolizumab plus\r\n      bevacizumab compared with active surveillance in participants with completely resected or\r\n      ablated hepatocellular carcinoma (HCC) who are at high risk for disease recurrence.",
        "brief_title": "A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation",
        "status_history": [
            {
                "status_date": "2022-01-05T00:00:00.000002",
                "status": "CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2019-11-25T00:00:00.000001",
                "status": "ACTIVE"
            },
            {
                "status_date": "2019-10-14T00:00:00",
                "status": "IN_REVIEW"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 662,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 7,
        "start_date": "2019-12-31",
        "record_verification_date": "2023-02-01",
        "ctep_id": null,
        "current_trial_status": "Closed to Accrual",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Randomized Controlled Trial"
        },
        "acronym": "IMbrave050",
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Liver"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2027-07-16",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]